Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs 8x8 Inc (EGHT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alnylam Pharmaceuticals, Inc. vs 8x8 Inc — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $221.5 (market cap $29.60B), while 8x8 Inc trades at $2.13 (market cap $309.09M). The key difference: Alnylam Pharmaceuticals, Inc. is far larger — about 95.8× 8x8 Inc's market cap, and 8x8 Inc is trading nearer its 52-week high, Alnylam Pharmaceuticals, Inc. nearer its low. Which is the better fit depends on your goals.
| ALNY | EGHT | |
|---|---|---|
Market Cap | $29.60B | $309.09M |
Sector | Health | Technology |
52-Week High | $491.22 | $2.76 |
52-Week Low | $205.48 | $1.59 |
Enterprise Value | $27.56B | $576.02M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Read more on ALNY →About 8x8 Inc
8x8 is a provider of integrated cloud communications and contact center solutions. Its platform combines voice, video, chat, and contact center functionality into a single application to help businesses collaborate.
Read more on EGHT →
